Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 12, 2013, Pages

  Morinelli, Thomas A ^a   Lee, Mi Hye ^a   Kendall, Ryan T ^a   Luttrell, Louis M ^a,b   Walker, Linda P ^a   Ullian, Michael E ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

arrestins; Angiotensin receptor; Cyclooxygenase 2; NF B; Signal transduction; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; BETA ARRESTIN 1; BETA ARRESTIN 2; CURCUMIN; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARTHENOLIDE; RADIOLIGAND; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; EMBRYO; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTERNALIZATION; LIGAND BINDING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; UBIQUITINATION; VASCULAR SMOOTH MUSCLE;

Β-ARRESTINS; ANGIOTENSIN RECEPTOR; CYCLOOXYGENASE-2; NF-ΚB; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELLS;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ARRESTINS; CELLS, CULTURED; HEK293 CELLS; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

RATTUS;

EID: 84879191249     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00235.2012     Document Type: Article

References (33)

1. Abdel Wahab N, Mason RM. Connective tissue growth factor and renal diseases: some answers, more questions. Curr Opin Nephrol Hypertens 13: 53-58, 2004.
2. Ahn S, Shenoy SK, Wei H, Lefkowitz RJ. Differential kinetic and spatial patterns of βarrestin and G protein-mediated ERK activation by the angiotensin II receptor. J Biol Chem 279: 35518-35525, 2004.
3. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res 80: 607-616, 1997.
4. Brasier AR. The nuclear factor-B-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211-218, 2010.
5. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-B (NF-κB) transcription factor. Mol Cell Biochem 212: 155-169, 2000.
6. Choudhary S, Lu M, Cui R, Brasier AR. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-B inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation. Mol Endocrinol 21: 2203-2217, 2007.
7. 536 nuclear factor B/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 99: 723-730, 2006.
8. Derbyshire ZE, Halfter UM, Heimark RL, Sy TH, Vaillancourt RR. Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II. Mol Cell Biochem 271: 77-90, 2005.
9. Douillette A, Bibeau-Poirier A, Gravel SP, Clement JF, Chenard V, Moreau P, Servant MJ. The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the I B kinase complex. J Biol Chem 281: 13275-13284, 2006.
10. Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G. Identification of βarrestin-2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways. Mol Cell 14: 303-317, 2004.
11. Guo RW, Yang LX, Wang H, Liu B, Wang L. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-B-dependent pathway in vascular smooth muscle cells. Regul Pept 147: 37-44, 2008.
12. Haendeler J, Berk BC. Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regul Pept 95: 1-7, 2000.
13. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1-F11, 2001.
14. Hoeppner CZ, Cheng N, Ye RD. Identification of a nuclear localization sequence in βarrestin-1 and its functional implications. J Biol Chem 287: 8932-8943, 2012.
15. Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303: 563-573, 2002.
16. Ji Y, Liu J, Wang Z, Liu N. Angiotensin II induces inflammatory response partly via Toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 23: 265-276, 2009.
17. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medicinal herb fever-few directly binds to and inhibits I B kinase. Chem Biol 8: 759-766, 2001.
18. Li XC, Zhuo JL. Nuclear factor-B as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens 17: 37-43, 2008.
19. Marrero MB, Schieffer B, Paxton WG, Duff JL, Berk BC, Bernstein KE. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovasc Res 30: 530-536, 1995.
20. Morinelli TA, Kendall RT, Luttrell LM, Walker LP, Ullian ME. Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. J Pharmacol Exp Ther 330: 118-124, 2009.
21. 1A receptor associated with nuclear activation. Am J Physiol Cell Physiol 292: C1398-C1408, 2007.
22. Morinelli TA, Walker LP, Ullian ME. Cox-2 expression stimulated by angiotensin II depends upon AT1 receptor internalization in vascular smooth muscle cells. Biochim Biophys Acta 1783: 1048-1054, 2008.
23. Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35: 68-75, 2000.
24. Swinney DC, Xu YZ, Scarafia LE, Lee I, Mak AY, Gan QF, Ramesha CS, Mulkins MA, Dunn J, So OY, Biegel T, Dinh M, Volkel P, Barnett J, Dalrymple SA, Lee S, Huber M. A small molecule ubiquitination inhibitor blocks NF-κB-dependent cytokine expression in cells and rats. J Biol Chem 277: 23573-23581, 2002.
25. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
26. Ullian ME, Gelasco AK, Fitzgibbon WR, Beck CN, Morinelli TA. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J Am Soc Nephrol 16: 2346-2353, 2005.
27. Vallabhapurapu S, Karin M. Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 27: 693-733, 2009.
28. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ. Independentβarrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100: 10782-10787, 2003.
29. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor I B. Proc Natl Acad Sci USA 101: 8603-8607, 2004.
30. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. Curcumin inhibits IL1 and TNF-induction of AP-1 and NF-κB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11: 49-62, 1997.
31. Yang M, He RL, Benovic JL, Ye RD. βArrestin-1 interacts with the G-protein subunits 1 2 and promotes 1 2-dependent Akt signalling for NF-κB activation. Biochem J 417: 287-296, 2009.
32. Yang M, Zhang H, Voyno-Yasenetskaya T, Ye RD. Requirement of G and c-Src in D2 dopamine receptor-mediated nuclear factor-B activation. Mol Pharmacol 64: 447-455, 2003.
33. Zahradka P, Werner JP, Buhay S, Litchie B, Helwer G, Thomas S. NF-κB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol 34: 1609-1621, 2002.